MDGL R&D to Revenue
Madrigal Pharmaceuticals Inc · R&D to Revenue
MDGL R&D to Revenue
Latest reported40.54%period ending
MDGL FY R&D/Revenue (0.00% → 40.54%)
Latest values, visible window
High-resolution chart · PNG
MDGL r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 40.5388% | |
| 131.4129% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 546.73% | |
| 271.9179% | |
| 35.3939% | |
| 3,119.7323% | |
| 7,002.0188% | |
| 0% | |
| 0% | |
| 22,043.9306% | |
| 1,866.3344% | |
| 0% | |
| 0% |